FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
FSTX
Delisted
FSTX was delisted on the 8th of March, 2023.
40 hedge funds and large institutions have $29M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
45% less capital invested
Capital invested by funds: $53.2M → $29M (-$24.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holding in Top 10
1
Calls
$72K
Puts
$12K
Top Buyers
| 1 | +$1.26M | |
| 2 | +$267K | |
| 3 | +$194K | |
| 4 |
Millennium Management
New York
|
+$144K |
| 5 |
Goldman Sachs
New York
|
+$120K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$530K | |
| 3 | -$466K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$442K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
-$397K |